Company Filing History:
1 out of 1,745 
1 out of 212 
1 out of 4 Years Active: 2021
Title: The Innovations of Serge Evrard: A Pioneer in Kidney Cancer Treatment
Introduction: Serge Evrard, based in Bordeaux, France, is a distinguished inventor known for his significant contributions to pharmaceutical innovations, particularly in the treatment of kidney cancer. With one notable patent to his name, his research marks a crucial advancement in the field of oncology.
Latest Patents: Evrard's patent titled "Methods and pharmaceutical compositions for the treatment of kidney cancer" discloses innovative methods and compositions aimed at combatting kidney cancer. His research reveals that Elabela (ELA), while predominantly expressed in healthy kidneys, shows reduced expression in human kidney cancer cases. Through experimental studies using a xenograft animal model, he demonstrated that Ela effectively inhibits tumor progression. This groundbreaking method involves administering a therapeutically effective amount of an ELA polypeptide, maintaining an amino acid sequence that closely resembles SEQ ID NO: 1, with specific mutations of arginine residues.
Career Highlights: Throughout his career, Serge Evrard has been associated with reputable institutions such as the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Université de Bordeaux. His work focuses on translating scientific research into practical therapeutic applications, particularly in the realm of cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations: Evrard has collaborated with notable professionals in the field, including Géraldine Siegfried and Abdel-Majid Khatib. These partnerships have bolstered his research efforts, leading to advancements in understanding and treating kidney cancer.
Conclusion: Serge Evrard's pioneering work holds the potential to transform kidney cancer treatment and demonstrates the importance of innovative research in addressing critical health challenges. As he continues to develop advanced therapeutic methods, his contributions will undoubtedly leave a lasting impact on the medical community and cancer patients worldwide.